1998. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med. 4(3):321. 76. Baar J. 1999. Clinical applications of dendritic cell cancer vaccines. Oncologist. 4:140. 77. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nature Med. 4(3):328. 78. Schuler-Thurner B., Dieckmann D., Keikavoussi P., Bender A., Maczek Ch., Jonuleit H., Röder C., Haendle I., Leisgang W., Dunbar R., Cerundolo V., Driesch P., Knop J., Bröcker E., Enk A., Kämpgen E., Schuler G. 2000. Mage-3 and influenza-matrix peptide-specific cytotoxic T cells are inducible in terminal stage HLA-A2.1+ melanoma patients by mature monocyte-derived dendritic cells. J immunol 165:3492. 79. Lau R., Wang F., Jeffery G., Marty V., Kuniyoshi J., Bade E., Ryback M., and Weber J. 2001. Phase I Trial Intravenous Peptide-Pulsed Dendritic Cells in Patients with Metastatic Melanoma. J. Immunotherapy 24(1):66. 80. Bendandi M., Gocke C.D., Kobrin C.B., Benko F.A., Sternas L.A., Pennington R., Watson T.M., Reynolds C.W., Gause B.L., Duffey P.L., Jaffe E.S., Creekmore S.P., Longo D.L., Kwak L.W. 1999. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma. Nature Med 5(10): 1171. 81. Mackall CL, Fleisher TA, Brown MR, et al. 1995. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med. 332:143. 82. Mackall CL, Fleisher TA, Brown MR, et al. 1994. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood. 84:2221. 83. Restifo NP, Kawakami Y, Marincola F, et al. 1993. Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I. J Immunother. 14:182. 84. Salazar-Onfray F. 1999. Interleukin-10: a strategy used by tumors to escape from immunesurveillance. (Review). Med.